Citations for
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D, Wilson K, Pridgeon S, Margetts JP, Edmondson RJ, Leung HY, Knox R, Boddy AV.
Clin Cancer Res 13(5):1584-90. 2007
Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
Kwiek JJ, Haystead TA, Rudolph J.
Biochemistry 43(15):4538-47. 2004
A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia.
Harada S, Tachikawa H, Kawanishi Y.
Psychiatr Genet 13(4):205-9. 2003
An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.
Harada S, Fujii C, Hayashi A, Ohkoshi N.
Biochem Biophys Res Commun 288(4):887-92. 2001
Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
Foster CE, Bianchet MA, Talalay P, Zhao Q, Amzel LM.
Biochemistry 38(31):9881-6. 1999
Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K, Knox R, Sun XZ, Joseph P, Jaiswal AK, Zhang D, Deng PS, Chen S.
Arch Biochem Biophys 347(2):221-8. 1997
Nucleotide and deduced amino acid sequence of a human cDNA (NQ02) corresponding to a second member of the NAD(P)H: quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK, et al.
Biochemistry 29 : 1899-1906. 1990